Nabi Biopharmaceuticals(NABI)

0.00 0.00 0.0%

今开：0.0昨收：10.8
最高：0.0 最低：0.0
涨停价：0.0跌停价：0.0
总市值：3.05964E8

Nabi Biopharmaceuticals的最新讨论

Coty 宣布完成收购金·卡戴珊个人美妆品牌 KKW Beauty 20％股份

华丽志2021-01-07 10:09

本周二，美国美妆巨头 Coty （科蒂）宣布完成以2亿美元收购美国网红 Kim Kardashian（金·卡戴珊）个人美妆品牌KKW Beauty 20％股份的交易。
这项交易最初是在去年6月份公布，Coty 计划为 KKW Beauty 扩展现有产品线，引入新的美容品类，包括在 2022 财政年度推出首个护肤系列。（详见《华丽志...查看全文

峰雾2011-09-11 01:24

关注$Nabi Biopharmaceuticals(NABI)$，当前价$1.75。查看全文

Eric0072011-09-06 17:48

关注$Nabi Biopharmaceuticals(NABI)$，当前价$1.82，目标价$2。查看全文

Nabi Biopharmaceuticals的公告

$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-02-09 AccNo: 0001437749-18-002182 Size: 222 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statem...

$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-02-09 AccNo: 0001437749-18-002181 Size: 21 KB 网页链接

$Nabi Biopharmaceuticals(NABI)$ DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Filed: 2018-02-09 AccNo: 0000921895-18-000480 Size: 38 KB 网页链接

$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-02-07 AccNo: 0001437749-18-001952 Size: 1 MB 网页链接

$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-02-07 AccNo: 0001437749-18-001951 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-02-07 AccNo: 0001437749-18-001952 Size: 1 MB 网页链接

$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-02-07 AccNo: 0001437749-18-001951 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-02-06 AccNo: 0001437749-18-001781 Size: 68 KB 网页链接

$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001437749-18-001780 Size: 67 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabi Biopharmaceuticals(NABI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-02-06 AccNo: 0001437749-18-001749 Size: 2 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11